✦ LIBER ✦

OC-0135 CAN PATIENT REPORTED OUTCOME MEASURES REPLACE CLINICAL ASSESSMENTS IN BREAST RADIOTHERAPY TRIALS?

✍ Scribed by J.S. Haviland; M. Sydenham; J. Mills; P. Hopwood; J.M. Bliss; J.R. Yarnold

Book ID: 119520309
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 69 KB
Volume: 103
Category: Article
ISSN: 0167-8140
DOI: 10.1016/s0167-8140(12)70474-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Standardizing Patient-Reported Outcomes

Standardizing Patient-Reported Outcomes Assessment in Cancer Clinical Trials: A Patient-Reported Outcomes Measurement Information System Initiative

✍ Garcia, S. F.; Cella, D.; Clauser, S. B.; Flynn, K. E.; Lad, T.; Lai, J.-S.; Ree 📂 Article 📅 2007 🏛 American Society of Clinical Oncology 🌐 English ⚖ 128 KB

PMC43 DATA POOLING OF PATIENT-REPORTED O

PMC43 DATA POOLING OF PATIENT-REPORTED OUTCOMES IN CLINICAL TRIALS: EVALUATION OF STATISTICAL TECHNIQUES FOR ASSESSING MEASUREMENT EQUIVALENCE

✍ M Nixon 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB

P284 Baseline assessment of patient-repo

P284 Baseline assessment of patient-reported outcomes (PROs) for breast cancer patients after 5-years of endocrine treatment in a randomized clinical trial: NSAS-BC 05

✍ H. Yagata; T. Iwase; H. Ohtsu; Y. Komoike; S. Saji; H. Takei; T. Nakamura; Y. Oh 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 36 KB

Comparison of Provider-Assessed and Pati

Comparison of Provider-Assessed and Patient-Reported Outcome Measures of Acute Skin Toxicity During a Phase III Trial of Mometasone Cream Versus Placebo During Breast Radiotherapy: The North Central Cancer Treatment Group (N06C4)

✍ Michelle A. Neben-Wittich; Pamela J. Atherton; David J. Schwartz; Jeff A. Sloan; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 120 KB